Literature DB >> 22371925

The relationship between clinical benefit and receipt of curative therapy for prostate cancer.

Ann C Raldow, Carolyn J Presley, James B Yu, Richa Sharma, Laura D Cramer, Pamela R Soulos, Jessica B Long, Danil V Makarov, Cary P Gross.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22371925      PMCID： PMC3491889          DOI： 10.1001/archinternmed.2011.1494

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  8 in total

1.  The 2010 NCCN clinical practice guidelines in oncology on prostate cancer.

Authors:  James L Mohler
Journal:  J Natl Compr Canc Netw       Date:  2010-02       Impact factor: 11.908

2.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

Review 3.  The quality of care. How can it be assessed?

Authors:  A Donabedian
Journal:  JAMA       Date:  1988 Sep 23-30       Impact factor: 56.272

4.  Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.

Authors:  David C Miller; Martin G Sanda; Rodney L Dunn; James E Montie; Hector Pimentel; Howard M Sandler; William P McLaughlin; John T Wei
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

5.  Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

Authors:  Paul L Nguyen; Xiangmei Gu; Stuart R Lipsitz; Toni K Choueiri; Wesley W Choi; Yin Lei; Karen E Hoffman; Jim C Hu
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

6.  Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer.

Authors:  Christian Bolenz; Amit Gupta; Timothy Hotze; Richard Ho; Jeffrey A Cadeddu; Claus G Roehrborn; Yair Lotan
Journal:  Eur Urol       Date:  2009-11-11       Impact factor: 20.096

7.  Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Authors:  Arnold L Potosky; William W Davis; Richard M Hoffman; Janet L Stanford; Robert A Stephenson; David F Penson; Linda C Harlan
Journal:  J Natl Cancer Inst       Date:  2004-09-15       Impact factor: 13.506

Review 8.  Intensity-modulated radiation therapy: supportive data for prostate cancer.

Authors:  Oren Cahlon; Margie Hunt; Michael J Zelefsky
Journal:  Semin Radiat Oncol       Date:  2008-01       Impact factor: 5.934
  8 in total
  2 in total

1.  Gleason score 6 adenocarcinoma: should it be labeled as cancer?

Authors:  H Ballentine Carter; Alan W Partin; Patrick C Walsh; Bruce J Trock; Robert W Veltri; William G Nelson; Donald S Coffey; Eric A Singer; Jonathan I Epstein
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

2.  Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study.

Authors:  Valesca P Retèl; Christine Bouchardy; Massimo Usel; Isabelle Neyroud-Caspar; Franz Schmidlin; Gregory Wirth; Christophe Iselin; Raymond Miralbell; Elisabetta Rapiti
Journal:  BMC Urol       Date:  2014-11-05       Impact factor: 2.264
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.